Europe Cell and Gene Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Cell and Gene Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Cell and Gene Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Cell and Gene Therapy Market Regional Analysis

6.2 Europe Cell and Gene Therapy Market Revenue 2021-2031 (US$ Million)

6.3 Europe Cell and Gene Therapy Market Forecast Analysis

7. Europe Cell and Gene Therapy Market Analysis – by Type

7.1 Cell Therapy

7.1.1 Overview
7.1.2 Cell Therapy: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Gene Therapy

7.2.1 Overview
7.2.2 Gene Therapy: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Cell and Gene Therapy Market Analysis – by Services

8.1 Process Development

8.1.1 Overview
8.1.2 Process Development: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 cGMP Manufacturing

8.2.1 Overview
8.2.2 cGMP Manufacturing: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Regulatory Services

8.3.1 Overview
8.3.2 Regulatory Services: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Bioassay Services

8.4.1 Overview
8.4.2 Bioassay Services: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Cell and Gene Therapy Market Analysis – by Scale

9.1 Pre Commercial/R

9.1.1 Overview
9.1.2 Pre Commercial/R: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 D Manufacturing

9.2.1 Overview
9.2.2 D Manufacturing: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Commercial Scale Manufacturing

9.3.1 Overview
9.3.2 Commercial Scale Manufacturing: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Cell and Gene Therapy Market Analysis – by Service Providers

10.1 CDMOs

10.1.1 Overview
10.1.2 CDMOs: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 CMOs

10.2.1 Overview
10.2.2 CMOs: Europe Cell and Gene Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Cell and Gene Therapy Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Cell and Gene Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
11.2.1.1 Europe Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UK: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.1.2 UK: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.1.3 UK: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.1.4 UK: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

11.2.1.2 Germany: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Germany: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.2.2 Germany: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.2.3 Germany: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.2.4 Germany: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

11.2.1.3 France: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 France: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.3.2 France: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.3.3 France: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.3.4 France: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

11.2.1.4 Italy: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Italy: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.4.2 Italy: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.4.3 Italy: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.4.4 Italy: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

11.2.1.5 Spain: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Spain: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.5.2 Spain: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.5.3 Spain: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.5.4 Spain: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

11.2.1.6 Rest of Europe: Europe Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Cell and Gene Therapy Market Breakdown, by Type
11.2.1.6.2 Rest of Europe: Europe Cell and Gene Therapy Market Breakdown, by Services
11.2.1.6.3 Rest of Europe: Europe Cell and Gene Therapy Market Breakdown, by Scale
11.2.1.6.4 Rest of Europe: Europe Cell and Gene Therapy Market Breakdown, by Service Providers

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Catalent Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Cell and Gene Therapy Catapult

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Charles River Laboratories International Inc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 F. Hoffmann-La Roche Ltd

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 FUJIFILM Holdings Corp

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Lonza Group AG

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Lotte Corp

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Merck KGaA

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Takara Bio Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Thermo Fisher Scientific Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 WuXi AppTec Co Ltd

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Cell and Gene Therapy Market